Searched for
DRUG MAKER FUNDING
ChrysCapital to take minority stake in Linux laboratoriesLinux Laboratories has secured $70 million in equity funding from ChrysCapital and Tata Capital Healthcare Fund III. This investment involv...- Global Market: China stocks edge up as policy support pledge lifts property sharesChinese mainland stocks edged higher as Beijing pledged stronger policy support to ease economic pressures, while Hong Kong shares fell. Pr...
- BRICS adopts New Delhi Declaration: Inside the 140-point document on Global South's ambitionsBRICS leaders adopted the New Delhi Declaration at the 18th summit, reaffirming their commitment to cooperation, multilateralism and a more...
- Temasek doubles down on India; sees long-term opportunities in family businessesTemasek International sees family businesses opening to investors as a major market shift. Generational transitions create attractive long-...
- Large pharma companies back appeal for TRIPS waiver for Covid-19 cure“We endorse the Indian government’s stand asking for a waiver of the TRIPS provisions to deal with the Covid-19 crisis. This is the time fo...
- Orchid gets three final bids at par with liquidation valueThe company had to sell assets to rein in debt. In 2012, it sold its penicillin business to US drug maker Hospira for $200 million.
- Daiichi shuts India R&D divisionThe R&D division was one of the last assets of the Japanese drug maker in India after it sold its generic pharma business of Ranbaxy to Sun...
- Cipla divests 16.7 per cent stake in Chase Pharma to AllerganChase was recently financed by a Series B consortium consisting of New Rhein Healthcare, Edmond de Rothschild Investment Partners and Cipla...
- Warburg Pincus offers $250 million for 11 per cent stake in rival ChrysCapital’s Mankind PharmaChrysCapital, which purchased the stake in 2007 for $24 mn will earn a 9-fold return, striking one of the largest exits in pharma sector by...
- Cadila Pharmaceuticals to set up SPV for funding innovation based startupsAhmedabad-based drug company, is looking for setting up a SPV for funding innovation done by individual or start-up firms in the field of d...
- US PE firm TA Associates in talks to buy 35% stake in drugmaker Famy Care for Rs 1,200 croreThe shareholders’ agreement between AIF Capital and the promoters gives a drag-along right to the fund in case of an exit.
- TA Associates in talks to buy 35% stake in Famy Care“TA Associates is in talks with the investors and Taparias, the promoters. The deal is expected to be signed post Diwali,” one of the perso...
- Warburg Pincus to pick 25% in Laurus Labs for $125-150 mnLaurus is a maker of active pharma ingredients for oncology and anti-retroviral drugs apart from specialty ingredients for nutraceutical in...
- ChrysCap to buy Rs 300-cr stake in Intas PharmaceuticalsPrivate equity firm ChrysCapital is buying an additional stake in Intas Pharmaceuticals for Rs 300 crore after the Ahmedabad-based drug mak...
- ChrysCapital set to raise stake in Intas Pharmaceuticals ahead of deferred IPOAlthough the stake could not be be confirmed, the pre-IPO deal will increase ChrysCapital's holding in the company to over 15% from 11.3% c...
- New drug regulatory norms on cardsRevamped policy to help drug cos become inventors and not copiers of MNC brands.
- New drug regulatory norms on cardsRevamped policy to help drug cos become inventors and not copiers of MNC brands.
- Pharma to get new regulatory regimeDrug makers in the country will get a new regulatory regime that is more friendly for investing heavily into high-risk research, testing ex...
- SME pharmas likely to get interest sopsThe government may provide an interest subsidy to small and medium-size pharma companies to upgrade their facilities in order to meet strin...
- Ranbaxy, Herbs & Cures bank on soft loans for researchLeading drug makers are increasingly going for government funding for their new drug research.
Load More
